☰

Jennifer L. Yori, Ph.D. - Publications

Affiliations: 
2011 Pharmacology Case Western Reserve University, Cleveland Heights, OH, United States 
Area:
Pharmacology, Oncology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Sahni JM, Gayle SS, Bonk KLW, Vite LC, Yori JL, Webb B, Ramos EK, Seachrist DD, Landis MD, Chang JC, Bradner JE, Keri RA. Correction: Bromodomain and extraterminal protein inhibition blocks growth of triple-negative breast cancers through the suppression of aurora kinases. The Journal of Biological Chemistry. 295: 9266. PMID 33516519 DOI: 10.1074/jbc.AAC120.014699  0.744
2020 Sahni JM, Gayle SS, Bonk KLW, Vite LC, Yori JL, Webb B, Ramos EK, Seachrist DD, Landis MD, Chang JC, Bradner JE, Keri RA. Correction: Bromodomain and extraterminal protein inhibition blocks growth of triple-negative breast cancers through the suppression of aurora kinases. The Journal of Biological Chemistry. 295: 9266. PMID 32620694 DOI: 10.1074/jbc.AAC120.014699  0.744
2018 Liao P, Yori J, Keri R, Koyuturk M, Barnholtz-Sloan J. Abstract 2262: Inference of kinase activity for cancer phosphoproteomics using substrate prediction scores Cancer Research. 78: 2262-2262. DOI: 10.1158/1538-7445.Am2018-2262  0.673
2016 Sahni JM, Gayle SS, Weber-Bonk KL, Cuellar Vite L, Yori JL, Webb B, Ramos EK, Seachrist DD, Landis MD, Chang JC, Bradner JE, Keri RA. Bromodomain and extraterminal protein inhibition blocks growth of triple-negative breast cancers through the suppression of Aurora kinases. The Journal of Biological Chemistry. PMID 27650498 DOI: 10.1074/Jbc.M116.738666  0.727
2014 Yori JL, Lozada KL, Seachrist DD, Mosley JD, Abdul-Karim FW, Booth CN, Flask CA, Keri RA. Combined SFK/mTOR inhibition prevents rapamycin-induced feedback activation of AKT and elicits efficient tumor regression. Cancer Research. 74: 4762-71. PMID 25023728 DOI: 10.1158/0008-5472.Can-13-3627  0.771
2013 Yori JL, Lozada K, Seachrist DD, Mosley J, Abdul-Karim FW, Booth CN, Flask CA, Keri RA. Abstract LB-221: Inhibition of rapamycin-induced feedback activation of AKT with dasatinib induces complete tumor regression in a preclinical model of breast cancer. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-221  0.768
2011 Yori JL, Seachrist DD, Johnson E, Lozada KL, Abdul-Karim FW, Chodosh LA, Schiemann WP, Keri RA. Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia (New York, N.Y.). 13: 601-10. PMID 21750654 DOI: 10.1593/Neo.11260  0.726
2010 Yori JL, Johnson E, Zhou G, Jain MK, Keri RA. Kruppel-like factor 4 inhibits epithelial-to-mesenchymal transition through regulation of E-cadherin gene expression. The Journal of Biological Chemistry. 285: 16854-63. PMID 20356845 DOI: 10.1074/Jbc.M110.114546  0.647
Show low-probability matches.